Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMS
AMS logo

AMS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy American Shared Hospital Services (AMS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.610
1 Day change
1.26%
52 Week Range
3.110
Analysis Updated At
2026/06/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

AMS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has short-term momentum, but there is no strong proprietary buy signal, no meaningful fundamental data to support a long-term entry, and the available catalyst and analyst information are too thin to justify an immediate purchase. If you want a direct answer: do not buy now; wait for clearer confirmation or better fundamentals.

Technical Analysis

The short-term technical picture is mildly positive but not strong enough for an immediate long-term buy. MACD histogram is positive and expanding, which supports near-term upward momentum. However, RSI_6 is 69.367, near overbought territory, and the moving averages are converging rather than showing a clean breakout trend. Price at 1.55 is above the pivot (1.468) and just under resistance R1 (1.556), so the stock is sitting right beneath a key ceiling. Support is below at 1.38 and 1.326. The stock also rose sharply in regular trading, but the post-market pullback suggests momentum may be cooling. Overall trend: constructive short term, but not an ideal fresh entry for a long-term beginner.

Positive Catalysts

  • Short-term technical momentum is positive, with an expanding MACD histogram and price holding above the pivot. The stock trend data suggests a potential 14.73% move over the next month based on similar candlestick patterns. Current price action also showed a strong regular-session gain, which indicates active buying interest.

Neutral/Negative Catalysts

  • There is no strong proprietary confirmation from Intellectia signals: AI Stock Picker shows no signal today and SwingMax shows no recent signal. Hedge funds and insiders are neutral with no notable accumulation. News flow is not directly relevant to AMS and does not provide a company-specific catalyst. The stock is trading near resistance, RSI is elevated, and the available financial snapshot is missing, so there is no strong fundamental support for a long-term beginner entry. Congress trading data is unavailable.

Financial Performance

Latest quarter financials are not available because the financial snapshot returned an error, so there is no usable quarter-season revenue or earnings growth data to assess. Based on the provided data, there is no evidence of a recent fundamental acceleration that would support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to support a bullish or bearish consensus. Based on the lack of analyst updates, Wall Street pros and cons appear neutral rather than strongly supportive.

Wall Street analysts forecast AMS stock price to rise
Analyst Rating
0
Wall Street analysts forecast AMS stock price to rise
Buy
Hold
Sell
0
Current: 1.580
sliders
Low
0
Averages
0
High
0
0
Current: 1.580
sliders
Low
0
Averages
0
High
0
JPMorgan
Overweight
to
NULL
downgrade
AI Analysis
2025-12-04
Reason
JPMorgan
Price Target
AI Analysis
2025-12-04
downgrade
Overweight
to
NULL
Reason
JPMorgan lowered the firm's price target on Amadeus IT Group to EUR 71 from EUR 75 and keeps an Overweight rating on the shares.

People Also Watch